A high level of CSF-1 or CSF-1R expression in the tumour or peri-tumoral tissue has been associated with poor patient survival in different malignancies such as lymphoma, breast cancer and hepatocellular carcinoma [94,95,96,97]. Here, CSF1R is linked to breast cancer.